Distribution of metals exposure and associations with cardiometabolic risk factors in the "modeling the Epidemiologic Transition Study"

Environmental Health: A Global Access Science Source

Volumn 13, Issue 1, 2014, Pages

  Ettinger, Adrienne S ^a   Bovet, Pascal ^b,c   Plange Rhule, Jacob ^d,e   Forrester, Terrence E ^f   Lambert, Estelle V ^g   Lupoli, Nicola ^h   Shine, James ^h   Dugas, Lara R ⁱ   Shoham, David ⁱ   Durazo Arvizu, Ramon A ⁱ   Cooper, Richard S ⁱ   Luke, Amy ⁱ  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c MINISTRY OF HEALTH   (Seychelles)

^d KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^e ST GEORGE S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF THE WEST INDIES   (Jamaica)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Arsenic; Cadmium; Cardiometabolic; Diabetes; Endocrine disruption; Lead; Mercury; Metals exposure; Obesity; Risk factor

Indexed keywords

ARSENIC; CADMIUM; LEAD; MERCURY; BIOLOGICAL MARKER; HEAVY METAL; POLLUTANT;

ARSENIC; BODY MASS; CADMIUM; CARDIOVASCULAR SYSTEM; CONCENTRATION (COMPOSITION); DIABETES; ENDOCRINE DISRUPTOR; ENERGY BALANCE; EPIDEMIOLOGY; LEAD; MERCURY (ELEMENT); OBESITY; POLLUTION EXPOSURE; RISK FACTOR; SOCIOECONOMIC STATUS;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY FAT; CARDIOMETABOLIC RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ECONOMIC DEVELOPMENT; EDUCATIONAL STATUS; EMPLOYMENT STATUS; ENERGY BALANCE; ENVIRONMENTAL EXPOSURE; FEMALE; FISH; FOOD INTAKE; GENDER; GHANA; GLUCOSE BLOOD LEVEL; HUMAN; JAMAICA; MALE; MARRIAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEYCHELLES; SMOKING; SOCIAL EVOLUTION; UNITED STATES; WEIGHT CHANGE; AFRICA; BLOOD; BODY WEIGHT; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; DRUG EFFECTS; MIDDLE AGED; POLLUTANT; RISK FACTOR;

GHANA; JAMAICA; SEYCHELLES; SOUTH AFRICA; UNITED STATES;

ADULT; AFRICA; ARSENIC; BIOMARKERS; BODY WEIGHT; CARDIOVASCULAR DISEASES; CHICAGO; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; JAMAICA; MALE; METALS, HEAVY; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84965091711     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-13-90     Document Type: Article

References (70)

1. Kuo CC, Moon K, Thayer KA, Navas-Acien A: Environmental chemicals and type 2 diabetes: An updated systematic review of the epidemiologic evidence. Curr Diab Rep 2013, 13:831-849.
2. Thayer KA, Heindel JJ, Bucher JR, Gallo MA: Role of environmental chemicals in diabetes and obesity: A National Toxicology Program workshop review. Environ Health Perspect 2012, 120:779-789.
3. Zeliger HI: Lipophilic chemical exposure as a cause of cardiovascular disease. Interdiscip Toxicol 2013, 6:55-62.
4. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, Bainbridge KE, Fradkin JE: Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010, 33:562-568.
5. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
6. Flegal KM, Carroll MD, Ogden CL, Curtin LR: Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303:235-241.
7. Ogden CL, Carroll MD, Kit BK, Flegal KM: Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014, 311:806-814.
8. Seidell JC: Obesity, insulin resistance and diabetes-A worldwide epidemic. Br J Nutr 2000, Suppl 1:S5-S8.
9. Baillie-Hamilton PF: Chemical toxins: A hypothesis to explain the global obesity epidemic. J Altern Complement Med 2002, 8:185-192.
10. Grön F, Blumberg B: Endocrine disrupters as obesogens. Mol Cell Endocrinol 2009, 304:19-29.
11. Longnecker MP, Daniels JL: Environmental contaminants as etiologic factors for diabetes. Environ Health Perspect 2001, 109:871-876.
12. Hyman MA: Environmental toxins, obesity, and diabetes: An emerging risk factor. Altern Ther Health Med 2010, 16:56-58.
13. Hu H: Exposure to metals. Prim Care 2000, 27:983-996.
14. Järup L: Hazards of heavy metal contamination. Br Med Bull 2003, 68:167-182.
15. Dyer CA: Heavy metals as endocrine-disrupting chemicals. In Endocrine-Disrupting Chemicals: From Basic Science to Clinical Practice. Edited by Gore AC. Totowa, NJ: Humana Press Inc; 2007.
16. Iavicoli I, Fontana L, Bergamaschi A: The effects of metals as endocrine disruptors. J Toxicol Environ Health B Crit Rev 2009, 12:206-223.
17. Tseng CH: The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol Appl Pharmacol 2004, 197:67-83.
18. Chen YW, Yang CY, Huang CF, Hung DZ, Leung YM, Liu SH: Heavy metals, islet function and diabetes development. Islets 2009, 1:169-176.
19. Watson WH, Yager JD: Arsenic: extension of its endocrine disruption potential to interference with estrogen receptor-mediated signaling. Toxicol Sci 2007, 98:1-4.
20. Kaltreider RC, Davis AM, Lariviere JP, Hamilton JW: Arsenic alters the function of the glucocorticoid receptor as a transcription factor. Environ Health Perspect 2001, 109:245-251.
21. Alissa EM, Ferns GA: Heavy metal poisoning and cardiovascular disease. J Toxicol 2011, 2011:870125. doi: 10.1155/2011/870125. Epub 2011 Sep 8.
22. Jomova K, Valko M: Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283:65-87.
23. Vaziri ND: Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol 2008, 295:H454-H465.
24. Moon K, Guallar E, Navas-Acien A: Arsenic exposure and cardiovascular disease: An updated systematic review. Curr Atheroscler Rep 2012, 14:542-555.
25. Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ: Lead exposure and cardiovascular disease-A systematic review. Environ Health Perspect 2007, 115:472-482.
26. Tellez-Plaza M, Jones MR, Dominguez-Lucas A, Guallar E, Navas-Acien A: Cadmium exposure and clinical cardiovascular disease: A systematic review. Curr Atheroscler Rep 2013, 15:356.
27. Virtanen JK, Rissanen TH, Voutilainen S, Tuomainen TP: Mercury as a risk factor for cardiovascular diseases. J Nutr Biochem 2007, 18:75-85.
28. Lee BK, Kim Y: Blood cadmium, mercury, and lead and metabolic syndrome in South Korea: 2005-2010 Korean National Health and Nutrition Examination Survey. Am J Ind Med 2013, 56:682-692.
29. Moon SS: Additive effect of heavy metals on metabolic syndrome in the Korean population: The Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Endocrine 2014, 46:263-271.
30. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005, 365:1415-1428.
31. Friedrich MJ: Studies probe mechanisms that have a role in obesityassociated morbidities. JAMA 2012, 308:1077-1079.
32. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH, American Heart Association, Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism: Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006, 113:898-918.
33. Eyre H, Kahn R, Robertson RM: Preventing cancer, cardiovascular disease, and diabetes: A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. CA Cancer J Clin 2004, 54:190-207.
34. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR: The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008, 168:1617-1624.
35. Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS, Blair SN: The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013, 34:389-397.
36. Hamer M, Stamatakis E: Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012, 97:2482-2488.
37. Hankinson AL, Daviglus ML, Van Horn L, Chan Q, Brown I, Holmes E, Elliott P, Stamler J: Diet composition and activity level of at risk and metabolically healthy obese American adults. Obesity 2013, 21:637-643.
38. Kramer CK, Zinman B, Retnakaran R: Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-Analysis. Ann Intern Med 2013, 159:758-769.
39. Luke A, Bovet P, Forrester TE, Lambert EV, Plange-Rhule J, Schoeller DA, Dugas LR, Durazo-Arvizu RA, Shoham D, Cooper RS, Brage S, Ekelund U, Steyn NP: Protocol for the modeling the epidemiologic transition study: A longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk. BMC Public Health 2011, 11:927.
40. United Nations Development Programme (UNDP): 2011 Human Development Report-Sustainability and Equity: A Better Future for All. [http://www.undp.org/content/undp/en/home/librarypage/hdr/human-developmentreport2011/]
41. Armstrong T, Bull F: Development of the World Health Organization Global Physical Activity Questionnaire (GPAQ). J Public Health 2006, 14:66-70.
42. World Health Organization (WHO): Global Physical Activity Questionnaire. [http://www.who.int/chp/steps/GPAQ/en/]
43. The World Bank Group: Core Welfare Indictor Questionnaire (CWIQ). [http://go.worldbank.org/66ELZUGJ30]
44. Huang PL: A comprehensive definition for metabolic syndrome. Dis Model Mech 2009, 2:231-237.
45. International Diabetes Federation (IDF): The IDF Consensus Worldwide Definition of Metabolic Syndrome. [http://www.idf.org/publications/idfconsensus-definition-metabolic-syndrome]
46. Centers for Disease Control and Prevention (CDC): Fourth National Report on Human Exposure to Environmental Chemicals-Updated Tables, September 2013. [http://www.cdc.gov/exposurereport]
47. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E: Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 2008, 300:814-822.
48. Schwartz GG, Il'yasova D, Ivanova A: Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care 2003, 26:468-470.
49. Schug TT, Janesick A, Blumberg B, Heindel JJ: Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 2011, 127:204-215.
50. Gluckman PD, Hanson MA, Pinal C: The developmental origins of adult disease. Matern Child Nutr 2005, 1:130-141.
51. Newbold RR, Padilla-Banks E, Jefferson WN: Environmental estrogens and obesity. Mol Cell Endocrinol 2009, 304:84-89.
52. Heindel JJ, vom Saal FS: Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol 2009, 304:90-96.
53. Galic S, Oakhill JS, Steinberg GR: Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010, 316:129-139.
54. Keller U: From obesity to diabetes. Int J Vitam Nutr Res 2006, 76:172-177.
55. Kurian AK, Cardarelli KM: Racial and ethnic differences in cardiovascular disease risk factors: A systematic review. Ethn Dis 2007, 17:143-152.
56. Food and Agriculture Organization (FAO): The double burden of malnutrition: case studies from six developing countries. [http://www.fao. org/ag/magazine/0602sp1.htm]
57. Goyer RA: Nutrition and metal toxicity. Am J Clin Nutr 1995, 61:646S-650S.
58. Peraza MA, Ayala-Fierro F, Barber DS, Casarez E, Rael LT: Effects of micronutrients on metal toxicity. Environ Health Perspect 1998, 106:203-216.
59. Sandström B: Micronutrient interactions: effects on absorption and bioavailability. Br J Nutr 2001, 85:S181-S185.
60. Gee GC, Payne-Sturges DC: Environmental health disparities: A framework integrating psychosocial and environmental concepts. Environ Health Perspect 2004, 112:1645-1653.
61. Pirkle JL, Brody DJ, Gunter EW, Kramer RA, Paschal DC, Flegal KM, Matte TD: The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). JAMA 1994, 272:284-291.
62. Muntner P, Menke A, DeSalvo KB, Rabito FA, Batuman V: Continued decline in blood lead levels among adults in the United States: The National Health and Nutrition Examination Surveys. Arch Intern Med 2005, 165:2155-2161.
63. Hicken MT, Gee GC, Morenoff J, Connell CM, Snow RC, Hu H: A novel look at racial health disparities: The interaction between social disadvantage and environmental health. Am J Public Health 2012, 102:2344-2351.
64. Beckie TM: A systematic review of allostatic load, health, and health disparities. Biol Res Nurs 2012, 14:311-346.
65. Onalaja AO, Claudio L: Genetic susceptibility to lead poisoning. Environ Health Perspect 2000, 108:23-28.
66. Garrick MD, Dolan KG, Horbinski C, Ghio AJ, Higgins D, Porubcin M, Moore EG, Hainsworth LN, Umbreit JN, Conrad ME, Feng L, Lis A, Roth JA, Singleton S, Garrick LM: DMT1: A mammalian transporter for multiple metals. Biometals 2003, 16:41-54.
67. Mims MP, Prchal JT: Divalent metal transporter 1. Hematology 2005, 10:339-345.
68. Ngueta G: Racial disparities in children's blood lead levels: possible implication of divalent metal transporter 1. Med Hypotheses 2014, 82:71-73.
69. Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, Sosa JA, Sumner AE, Anton B: Health disparities in endocrine disorders: biological, clinical, and nonclinical factors-An Endocrine Society scientific statement. J Clin Endocrinol Metab 2012, 97:E1579-E1639.
70. Olden K, White SL: Health-related disparities: influence of environmental factors. Med Clin North Am 2005, 89:721-738.